NEW YORK, April 9, 2007 /PRNewswire via COMTEX/ -- Telomerase Activation
Sciences, Inc. (TA Sciences) announced on March 12 its license with Geron to
develop and market non-therapeutic products using Geron's small molecule
telomerase activators. Now TA Sciences announces the opening of the TA Sciences
Center in Manhattan where customers can purchase TA Sciences' first product, a
nutraceutical containing the telomerase activating agent "TA-65."
"TA Sciences welcomes our first customers and the launch of the world's first
telomerase activator product," said Noel Thomas Patton, founder of TA Sciences.
"A natural consequence of aging is the shortening of telomeres (caps of DNA
located at the ends of all chromosomes), which ultimately results in loss of
cell function. TA-65 offers the potential of reducing or reversing telomere
shortening and battles tissue and organ degeneration by rejuvenating aging
cells."
TA-65 is the result of vigorous scientific research that began at Geron in 1992.
Already the response from the scientific community to the news of TA Sciences'
ground-breaking launch has been very enthusiastic: "Telomerase Activation is the
single most promising approach to reversing the effects of aging," said Michael
Fossel, MD, PhD., Clinical Professor of Medicine at Michigan State University,
author, and recognized authority on aging and age- related clinical disease.
And Dr. William H. Andrews, founder of Sierra Sciences, LLC and one of the
principal discoverers of the telomerase genes, said: "Cleopatra, Ponce de Leon,
and untold others throughout the ages have searched for the secrets of youth.
That search has been futile, until now: Telomerase Activation is the first and
only scientifically sound way to approach anti- aging. TA-65 is the first
product in history that has been proven to slow or reverse cellular aging.
Congratulations to TA Sciences and Geron!"
On April 30, 2007 TA Sciences plans to publish the results of the Pivotal 2005
Anti-Aging Trial, which is the first ever human clinical trial of a telomerase
activator. This trial shows statistical verification of the anti- aging benefits
of telomerase activation.
The TA Sciences Center is located at 24 E. 64th Street in New York. The company
offers its telomerase-activating products as part of the 12 month "Patton
Protocol." The driver of TA Sciences' product line is the telomerase- activating
small molecule "TA-65," sold under license from Geron. For more information on
TA Sciences visit http://www.TASciences.com or call 888-360-8886. For more
information on Geron visit http://www.Geron.com.
SOURCE TA Sciences Inc.
CONTACT: Greta Blackburn of TA Sciences Inc., cell, +1-818-634-5941
URL: http://www.tasciences.com
http://www.Geron.com
http://www.prnewswire.com
www.prnewswire.com